Navigation Links
E-Rad Solutions Selects Compressus' Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market
Date:11/26/2007

MEDxConnect(TM) System Provides Ability to Integrate with Multiple

Disparate PACS and RIS Systems Simultaneously to Improve Physician

Efficiency and Diagnostic Turnaround

CHICAGO, Nov. 26 /PRNewswire/ -- RSNA Booth #5924 -- Compressus Inc., makers of the MEDxConnect(TM) technology for seamless connectivity and interoperability between diagnostic acquisition devices, PACS, HIS, RIS, and related information systems, announced today that E-Rad Solutions of Palm Beach Gardens, Fla., has selected the MEDxConnect System to fuel its entry into the teleradiology market. The company made the announcement here at 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 25-30, 2007.

E-Rad Solutions is an innovative teleradiology company offering customized support services, including on call, overflow, on site, subspecialty, and routine coverage in all modalities. Using state of the art technology to help hospitals and radiology groups improve workflow, enhance delivery of high quality patient care, and optimize satisfaction and financial performance of radiology practices, E-Rad Solutions will implement the MEDxConnect technology on behalf of its first client, a three hospital group in Florida.

"Looking to launch a new service model designed to simplify and automate the teleradiology process for our clients, we evaluated a number of PACS and RIS technology providers. What we found was that only Compressus provides the ability to truly integrate into multiple disparate PACS and RIS systems simultaneously without the need to be tied to one platform," said Mark Gonwa, MD, radiologist and president of E-Rad Solutions. "This flexibility gives E-Rad Solutions a cost-effective solution to provide comprehensive teleradiology services with seamless, automated connectivity throughout the entire process, from order entry to delivery of the diagnostic report to referring physicians
'/>"/>

SOURCE Compressus Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
2. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
3. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
4. BioLife Solutions Expands Scientific Advisory Board
5. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
6. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
7. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
8. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
9. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
10. Cardiosolutions Raises $7 Million for Spacer Technology to Mitigate Mitral Regurgitation
11. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Salt Lake City, Utah (PRWEB) August 27, 2014 ... new construction that will expand its current Salt Lake ... operations currently underway outside of Utah to ultimately create ... the next 20 years. , “Utah is home ... many of whom can be credited with Varian’s success ...
(Date:8/27/2014)... Green & Grow Inc. (GGI) has ... and secured Otter Capital as a significant new partner. ... of GGI’s Agriplier™ technology, building on recent compelling field ... our first meeting, we have been impressed with Otter ... said Alan Sobba, President and CEO of GGI. “We ...
(Date:8/27/2014)... 2014 Rhythm, a biopharmaceutical company developing peptide ... result in metabolic disorders, announced today that it has ... U.S. Securities and Exchange Commission (SEC) relating to the ... stock. The number of shares to be offered and ... been determined. Citigroup and Cowen and Company ...
(Date:8/27/2014)... August 27, 2014 In 2013, ... Lawrence Livermore National Security LLC (LLNS), ... and deliver a state-of-the-art laser system for the ... Beamlines), under construction in the Czech Republic. , ... laser system, called the " High repetition-rate Advanced ...
Breaking Biology Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3
... Company now officially following an FDA 510(k) (Pre-Market Notification), Pathway for ... ... Human Appendicitis, CASTLE ROCK, Colo., Nov. 27 AspenBio Pharma,Inc. ... of novel drugs and diagnostics for animals and humans, has,received an ...
... Shamir,Optical Industry Ltd. (Nasdaq: SHMR ) ("Shamir"), a ... ophthalmic lens,market, today announced unaudited financial results for the ... ended September 30, 2007, revenues increased by 28.5%,to $30.9 ... of 2006.,Gross profit for the quarter increased by 25.3% ...
... Masimo receives approval from Ministry of Health, Labor and Welfare ... carbon ... monoxide levels in the blood, IRVINE, Calif., ... Motion and Low Perfusion pulse,oximetry, today announced approval of the ...
Cached Biology Technology:AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test 2AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test 3AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test 4Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results 2Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results 3Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results 4Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results 5Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results 6Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results 7Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results 8Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results 9Shamir Optical Industry Ltd. Reports Third Quarter 2007 Results 10Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan 2Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan 3Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan 4
(Date:8/27/2014)... that a single fungal cell or bacterial colony exerts on ... a heavy role in setting up some of the most ... be too much of a stretch to say that plants ... respond to the touch of beneficial fungi, according to a ... at the University of Wisconsin-Madison. , "Many people have ...
(Date:8/27/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... offering of units of common stock and warrants at ... of $20 million, prior to deducting underwriting discounts and ... shares and warrants are immediately separable and will be ... the offering consists of 2,000 shares of common stock ...
(Date:8/27/2014)... bears, giant ground sloths, saber-toothed cats and American camels ... at the end of the Pleistocene period. The cause ... scientists who, until recently, could only speculate as to ... Barbara,s James Kennett, professor emeritus in the Department of ... played a major role in the extinction. Their hypothesis ...
Breaking Biology News(10 mins):A touching story: The ancient conversation between plants, fungi and bacteria 2A touching story: The ancient conversation between plants, fungi and bacteria 3WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3Nanodiamonds are forever 2Nanodiamonds are forever 3
... everyone will see the light and start living more ... may be doing more harm than good. So ... a provocative essay in the March 2009 issue of ... Vucetich, assistant professor of animal ecology at Michigan Technological ...
... New York, NY) The Parkinson,s Disease Foundation (PDF) has ... Parkinson,s disease scientists. The grants will sustain promising ... sudden collapse of their primary private funder, The Picower ... by Bernard Madoff, was forced to cease all grantmaking ...
... scientists is renewing calls for policymakers to reduce both ... or nutrient pollution problems in fresh and coastal ... , the researchers argue that dual-nutrient reduction strategies are ... between nitrogen and phosphorus in fresh and coastal water ...
Cached Biology News:Abandon hope 2Parkinson's Disease Foundation awards $300,000 in bridge funding for innovative research projects 2Parkinson's Disease Foundation awards $300,000 in bridge funding for innovative research projects 3
MAb to Vasopressin Preservative: NaN3...
Mouse monoclonal [0.N.509] to PCTAIRE2 ( Abpromise for all tested applications). entrezGeneID: 5128 SwissProtID: Q00537...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
... Spin Columns contain a proprietary high-performance desalting ... desalting and protein-recovery characteristics compared to other ... as 25 g/ml of protein can be ... 95% retention of salts and other small ...
Biology Products: